The role of histone methylation in renal cell cancer: an update

Mol Biol Rep. 2023 Mar;50(3):2735-2742. doi: 10.1007/s11033-022-08124-3. Epub 2022 Dec 28.

Abstract

Renal cell carcinoma accounts for 2-3% of all cancers. It is difficult to diagnose early. Recently, genome-wide studies have identified that histone methylation was one of the functional classes that is most frequently dysregulated in renal cell cancer. Mutation or mis-regulation of histone methylation, methyltransferases, demethylases are associated with gene expression and tumor progression in renal cell cancer. Herein, we summarize histone methylations, demethylases and their alterations and mechanisms in renal cell cancer.

Keywords: Dot1l; Ezh2; Histone methylation; Lysine methyltransferases; Renal cell cancer.

Publication types

  • Review

MeSH terms

  • Carcinoma, Renal Cell* / genetics
  • Histone-Lysine N-Methyltransferase / genetics
  • Histone-Lysine N-Methyltransferase / metabolism
  • Histones / genetics
  • Histones / metabolism
  • Humans
  • Kidney Neoplasms* / genetics
  • Methylation

Substances

  • Histones
  • Histone-Lysine N-Methyltransferase